Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio.
Pancreatic islet transplantation is a promising treatment for type 1 diabetes (T1D). Interleukin-35 (IL-35) is a recently discovered cytokine that exhibits potent immunosuppressive functions. However, the role of IL-35 in islet transplant rejection remains to be elucidated. In this study, we isolate...
Main Authors: | Yin Zongyi, Zou Funian, Li Hao, Wang Xin, Cheng Ying, Zhang Jialin, Liu Yongfeng, Li Baifeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5728515?pdf=render |
Similar Items
-
A rapid, efficient, and economic device and method for the isolation and purification of mouse islet cells.
by: Yin Zongyi, et al.
Published: (2017-01-01) -
Increased Th17/Treg Ratio in Poststroke Fatigue
by: Xinjing Liu, et al.
Published: (2015-01-01) -
Interleukin 35 induced Th2 and Tregs bias under normal conditions in mice
by: Xiaoning Zhang, et al.
Published: (2018-09-01) -
Treg/IL-17 ratio and Treg differentiation in patients with COPD.
by: Yang Jin, et al.
Published: (2014-01-01) -
The Expression of Notch/Notch Ligand, IL-35, IL-17, and Th17/Treg in Preeclampsia
by: Weiping Cao, et al.
Published: (2015-01-01)